Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

IntrepidaBio is a preclinical biotechnology company dedicated to developing cures for cancer through drugs that alter the body’s first line of defense, innate immunity. Intrepida Bio is a preclinical company dedicated to developing cures for cancer via drugs that alter the body’s first line of defense, the innate immune system. We are developing products derived from the breakthrough research of Dr. Maria Caterina Turco a...
IntrepidaBio is a preclinical biotechnology company dedicated to developing cures for cancer through drugs that alter the body’s first line of defense, innate immunity. Intrepida Bio is a preclinical company dedicated to developing cures for cancer via drugs that alter the body’s first line of defense, the innate immune system. We are developing products derived from the breakthrough research of Dr. Maria Caterina Turco at the University of Salerno. Dr. Turco discovered a biological pathway that tumors use to subvert the innate immune system to do their bidding by producing an environment that encourages tumor growth.

List your booth number for exhibitions, ask us